A patient diagnosed with moderate preeclampsia is receiving magnesium sulfate therapy. Which assessment finding should the nurse prioritize as an indication of magnesium sulfate toxicity?

B) Respiratory rate of 10 breaths per minute

A) Blood pressure of 150/95 mmHg

B) Respiratory rate of 10 breaths per minute

D) Fetal heart rate of 140 beats per minute with moderate variability

A nurse is caring for a patient diagnosed with moderate preeclampsia. The healthcare team has initiated magnesium sulfate therapy to prevent seizures. Which of the following signs should prompt the nurse to consider the possibility of magnesium sulfate toxicity in the patient?

A) Decreased deep tendon reflexes

D) Complaints of epigastric pain

A patient with worsening preeclampsia is exhibiting signs consistent with HELLP syndrome and requires immediate intervention. Which of the following nursing actions is the priority to address the patient's current condition?

B) Prepare the patient for an emergency cesarean section.

A) Administer additional antihypertensive medication as prescribed.

B) Prepare the patient for an emergency cesarean section.

C) Increase the rate of intravenous magnesium sulfate infusion.

D) Provide the patient with oxygen via nasal cannula.

A patient with severe preeclampsia is showing signs of developing HELLP syndrome. Her blood pressure is 165/105 mmHg and she is experiencing a severe headache, epigastric pain, and visual disturbances. Laboratory results indicate a platelet count of 90,000/μL and elevated liver enzymes. What is the priority nursing intervention?

B) Prepare the patient for an emergency cesarean section to expedite delivery.

A) Administer additional antihypertensive medications to control blood pressure.

B) Prepare the patient for an emergency cesarean section to expedite delivery.

C) Increase the rate of magnesium sulfate infusion to prevent seizures.

D) Monitor urine output closely and report any further decrease to the provider.

A postpartum patient in the ICU is being monitored after an emergency cesarean section due to suspected eclampsia and HELLP syndrome. Her blood pressure is currently stabilized with antihypertensive medication and magnesium sulfate, but the nurse notes that the patient's urine output has dropped to 20 mL/hour. What is the priority nursing intervention at this time?

B) Notify the healthcare provider immediately due to oliguria.

A) Increase the rate of IV fluids to improve renal perfusion.

B) Notify the healthcare provider immediately due to oliguria.

C) Assess the patient's deep tendon reflexes for magnesium toxicity.

D) Re-evaluate the patient's blood pressure to ensure stability.

A patient in the intensive care unit with a history of pre-eclampsia is exhibiting neurological changes, including a severe headache and decreased Glasgow Coma Scale score. Which nursing intervention is the highest priority to prevent potential complications?

A) Administer prescribed magnesium sulfate to prevent seizures

B) Increase the frequency of vital signs monitoring

C) Prepare the patient for a head CT scan

D) Administer prescribed antihypertensives to manage blood pressure

A patient in the intensive care unit post-operatively is exhibiting a decrease in Glasgow Coma Scale score to 11, severe headache, and confusion. Which nursing intervention should be prioritized to address the potential complications associated with these symptoms?

B) Prepare the patient for a CT scan to assess for possible intracranial hemorrhage or cerebral edema.

A) Administer acetaminophen to relieve the headache and monitor for pain relief.

B) Prepare the patient for a CT scan to assess for possible intracranial hemorrhage or cerebral edema.

C) Increase the frequency of blood pressure monitoring to detect any hypertensive spikes.

D) Encourage fluid intake to prevent dehydration and maintain renal function.

A patient with severe pre-eclampsia and HELLP syndrome is receiving continuous labetalol infusion for blood pressure control and magnesium sulfate for seizure prophylaxis. Her latest arterial blood gas shows a pH of 7.47 and a PaCO2 of 31 mmHg, indicating mild respiratory alkalosis. What is the most appropriate nursing intervention to address the respiratory status of this patient?

A) Increase the infusion rate of magnesium sulfate to manage potential respiratory depression.

B) Administer a sedative to reduce anxiety and lower the respiratory rate.

D) Encourage the patient to take slow, deep breaths to reduce respiratory alkalosis.

A patient with severe pre-eclampsia and suspected HELLP syndrome is experiencing mild respiratory alkalosis with a respiratory rate of 24 breaths per minute. Which nursing intervention is most appropriate to address the underlying cause of her increased respiratory rate?

A) Administering a sedative to reduce anxiety

B) Increasing the rate of magnesium sulfate infusion

C) Providing supplemental oxygen via nasal cannula

D) Positioning the patient in a high Fowler's position

maternity - Nursing Case Study

Pathophysiology

• Primary mechanism: Hormonal changes - Pregnancy triggers elevated levels of hormones such as estrogen, progesterone, and human chorionic gonadotropin (hCG), which are crucial for maintaining the pregnancy and supporting fetal development. These hormones prepare the endometrium for implantation and modulate maternal systems to accommodate the growing fetus.

• Secondary mechanism: Placental function - The placenta serves as a critical organ for nutrient and oxygen exchange between the mother and fetus. It also produces hormones necessary for pregnancy maintenance. Placental insufficiency can lead to complications like intrauterine growth restriction (IUGR) and preeclampsia.

• Key complication: Preeclampsia - Characterized by hypertension and proteinuria after 20 weeks of gestation, preeclampsia arises from abnormal placentation and poor trophoblastic invasion, leading to reduced placental perfusion and systemic endothelial dysfunction, posing risks to both the mother and fetus.

Patient Profile

Demographics:

28-year-old female, office manager

History:

• Key past medical history: Gestational diabetes in a previous pregnancy

• Current medications: Prenatal vitamins, insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and persistent headache

• Key symptoms: Swelling in the feet and hands, fatigue, blurred vision

• Vital signs: Blood pressure 150/95 mmHg, heart rate 95 bpm, respiratory rate 22 breaths per minute, temperature 37.1°C (98.8°F)

Section 1

Initial Assessment Findings:

Upon further assessment, the patient's condition appears to be consistent with moderate preeclampsia. Her blood pressure remains elevated at 150/95 mmHg despite resting, and she presents with significant edema in her lower extremities and hands. Urinalysis reveals proteinuria with a protein level of +2, confirming the suspicion of preeclampsia. The patient reports worsening fatigue and blurred vision, which raises concerns about potential cerebral involvement. The fetal heart rate is monitored and shows a baseline of 140 beats per minute with moderate variability, indicating that the fetus is currently stable, but continuous monitoring is warranted due to the potential for rapid changes in maternal condition.

The patient's laboratory results further delineate the situation: her platelet count has decreased to 110,000/μL, and liver function tests show mildly elevated liver enzymes, with AST at 45 U/L and ALT at 50 U/L. These findings suggest that the patient may be evolving towards a more severe form of preeclampsia, known as HELLP syndrome, characterized by hemolysis, elevated liver enzymes, and low platelet count. Given these findings, the interdisciplinary team decides to initiate magnesium sulfate therapy to prevent seizures and monitor for any signs of disease progression.

The clinical team discusses the plan with the patient, emphasizing the importance of close monitoring and the possibility of early delivery if her condition worsens or if the fetal status becomes compromised. The patient is educated on the symptoms of worsening preeclampsia, such as increased headache, visual disturbances, or epigastric pain, which should be reported immediately. This approach ensures vigilant monitoring and timely intervention, aiming to minimize risks to both the mother and fetus as the situation progresses.

Section 2

As the clinical team continues to monitor the patient's condition, a new complication arises. Approximately 12 hours after the initiation of magnesium sulfate therapy, the patient begins to exhibit signs of worsening preeclampsia with potential onset of HELLP syndrome. Her blood pressure escalates further to 165/105 mmHg, despite the administration of antihypertensive medications. The patient reports a persistent, severe headache and increased epigastric pain, suggestive of liver involvement. Her visual disturbances have also intensified, with more frequent episodes of blurred vision and photophobia.

In response to these alarming symptoms, additional laboratory tests are ordered. The results reveal a further decline in the platelet count to 90,000/μL, and a notable increase in liver enzyme levels, with AST rising to 80 U/L and ALT to 95 U/L. These findings corroborate the clinical suspicion of HELLP syndrome, indicating the need for urgent intervention. The patient's urine output is also monitored and shows oliguria, with output reduced to 15 mL/hour, raising concerns about potential renal impairment.

Given the rapid progression of the patient's condition and the risk of complications such as eclampsia or placental abruption, the interdisciplinary team convenes to reassess the management plan. They determine that immediate delivery is necessary to safeguard both maternal and fetal well-being. The patient and her family are informed of the need for an expedited delivery, and preparations for an emergency cesarean section are initiated. This decision underscores the critical nature of early recognition and intervention in managing preeclampsia with severe features, highlighting the importance of continuous assessment and timely clinical judgment.

Section 3

As the medical team prepares for the emergency cesarean section, the patient's condition undergoes a significant change. In the operating room, the anesthesia team performs a rapid assessment to determine the most appropriate anesthesia plan. The patient is found to be increasingly lethargic, and her Glasgow Coma Scale score has decreased to 13, indicating a possible progression toward eclampsia. Her blood pressure remains elevated at 170/110 mmHg despite ongoing treatment, and her reflexes are brisk with 3+ deep tendon reflexes, suggesting heightened neuromuscular excitability.

During the procedure, fetal heart rate monitoring reveals late decelerations, a sign of fetal distress that corroborates the urgency of the situation. The surgical team swiftly proceeds with the cesarean delivery, and a male infant is delivered with Apgar scores of 6 and 8 at one and five minutes, respectively. The neonate requires brief resuscitation, including positive pressure ventilation, before stabilizing.

Post-operatively, the patient's condition is closely monitored in the intensive care unit. Her blood pressure gradually stabilizes with the continued administration of antihypertensive medication and magnesium sulfate. The team observes cautious optimism as her urine output begins to improve slightly, reaching 25 mL/hour, suggesting tentative renal recovery. The interdisciplinary team discusses plans for ongoing surveillance of liver function and coagulation status, emphasizing the necessity of vigilance in detecting any further complications. The immediate delivery has mitigated further deterioration, yet the patient remains under close observation to address any potential sequelae of HELLP syndrome and ensure her recovery.

Section 4

As the patient settles into the intensive care unit, the medical team remains vigilant for any new complications that may arise post-operatively. Despite the initial stabilization, the nursing staff notices a change in the patient's neurological status. The patient begins to complain of a severe headache and experiences a slight increase in confusion, raising concerns about potential cerebral involvement. Her Glasgow Coma Scale score has decreased further to 11, prompting the team to reassess her condition urgently. Repeat evaluation of her reflexes shows persistent briskness, and clonus is noted at the ankle, indicating potential worsening of her pre-eclamptic state.

In response to these developments, the team orders a series of diagnostic tests, prioritizing a head CT to rule out intracranial hemorrhage or cerebral edema, both of which could complicate her recovery. Concurrently, laboratory results reveal a slight increase in liver enzymes and a mild thrombocytopenia, with platelet counts now at 95,000/mm³, suggesting that HELLP syndrome remains a significant concern. These findings necessitate adjustments in the management plan, including a possible increase in the magnesium sulfate dosage to ensure seizure prophylaxis and careful titration of antihypertensives to manage her blood pressure without compromising cerebral perfusion.

Given her evolving status, the interdisciplinary team deliberates on the need for more intensive monitoring and potential escalation of care. The continuation of strict neurological assessments is prioritized, alongside close observation of fluid status and renal function, as these will guide further interventions. This comprehensive approach is essential to navigate the delicate balance of managing her hypertensive crisis while preventing further eclamptic events, thereby safeguarding both maternal and fetal outcomes as she progresses through her recovery.

Section 5

As the team continues to monitor the patient's condition, the head CT scan results return, showing no evidence of intracranial hemorrhage but mild cerebral edema. This finding supports the suspicion of severe pre-eclamptic complications, now compounded by signs of HELLP syndrome. The medical team decides to adjust the patient's management plan, focusing on optimizing her blood pressure control and cerebral perfusion. Her blood pressure remains elevated at 165/110 mmHg despite initial treatment; thus, they opt to carefully titrate her antihypertensive regimen, introducing labetalol via continuous infusion to achieve gradual reduction in blood pressure.

Meanwhile, the patient's neurological status is closely monitored. The nursing team conducts frequent assessments, noting any changes in her level of consciousness or the presence of additional neurological signs. Repeat Glasgow Coma Scale scores remain between 10 and 11, indicating ongoing impairment. To address the risk of seizures, the magnesium sulfate infusion is increased slightly, and serum magnesium levels are monitored closely to maintain them within the therapeutic range of 4-7 mg/dL. Additionally, her fluid intake is meticulously balanced against output to prevent exacerbation of cerebral edema, with careful monitoring of renal function through serum creatinine and urine output.

Despite these interventions, new complications arise as the patient's respiratory rate increases to 24 breaths per minute, and she develops mild respiratory alkalosis, as evidenced by an arterial blood gas analysis showing a pH of 7.47 and a PaCO2 of 31 mmHg. The interdisciplinary team evaluates these findings, considering potential causes such as anxiety, pain, or a response to the magnesium sulfate. They decide to provide supplemental oxygen to maintain adequate oxygenation and continue to assess her respiratory status closely. This comprehensive management highlights the ongoing challenges in balancing the multifaceted aspects of her care, emphasizing the need for continuous reassessment and collaboration to optimize both maternal and fetal outcomes.